CSNpharm
Laquinimod is an orally administered neuroimmunomodulator initially developed for the treatment of multiple sclerosis.
More Information
Supplier Page
CSNpharm
Laquinimod is an orally administered neuroimmunomodulator initially developed for the treatment of multiple sclerosis.
More Information
Supplier Page
CSNpharm
Laquinimod is an orally administered neuroimmunomodulator initially developed for the treatment of multiple sclerosis.
More Information
Supplier Page
CSNpharm
Lariciresinol, a natural product isolated and purified from the herbs of Phyllanthus niruri, possesses fungicidal activities by disrupting the fungal plasma membrane. (-)-Lariciresinol and its 7S,8S,8’R stereoisomer can inhibit the root growth of Italian ryegrass to 51-55% relative to the negative control.
More Information
Supplier Page
CSNpharm
Lariciresinol, a natural product isolated and purified from the herbs of Phyllanthus niruri, possesses fungicidal activities by disrupting the fungal plasma membrane. (-)-Lariciresinol and its 7S,8S,8’R stereoisomer can inhibit the root growth of Italian ryegrass to 51-55% relative to the negative control.
More Information
Supplier Page
CSNpharm
Lariciresinol, a natural product isolated and purified from the herbs of Phyllanthus niruri, possesses fungicidal activities by disrupting the fungal plasma membrane. (-)-Lariciresinol and its 7S,8S,8’R stereoisomer can inhibit the root growth of Italian ryegrass to 51-55% relative to the negative control.
More Information
Supplier Page
CSNpharm
Lariciresinol dimethyl ether is a natural product isolated and purified from the herbs of Rostellularia procumbens.
More Information
Supplier Page
CSNpharm
Lariciresinol dimethyl ether is a natural product isolated and purified from the herbs of Rostellularia procumbens.
More Information
Supplier Page
CSNpharm
Lasiodiplodin, a natural product isolated and purified from the herbs of Derris robusta, inhibits electron transport chain and shows moderate suppression effects on induced NO production, suggest that it may have potential anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
Lasiodiplodin, a natural product isolated and purified from the herbs of Derris robusta, inhibits electron transport chain and shows moderate suppression effects on induced NO production, suggest that it may have potential anti-inflammatory activity.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.
More Information
Supplier Page
CSNpharm
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.
More Information
Supplier Page
CSNpharm
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.
More Information
Supplier Page
CSNpharm
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.
More Information
Supplier Page
CSNpharm
Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral outflow and thereby reduces intraocular pressure.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Latrepirdine is an orally-available drug, approved in Russia for use as a non-selective antihistamine, that has shown promise in the treatment of neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. In addition to reported activity in preventing the onset and progression of disease by being neuroprotective, dimebolin appears to promote clinical improvement by increasing cognitive function. […]
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally-available drug, approved in Russia for use as a non-selective antihistamine, that has shown promise in the treatment of neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. In addition to reported activity in preventing the onset and progression of disease by being neuroprotective, dimebolin appears to promote clinical improvement by increasing cognitive function. […]
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally-available drug, approved in Russia for use as a non-selective antihistamine, that has shown promise in the treatment of neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. In addition to reported activity in preventing the onset and progression of disease by being neuroprotective, dimebolin appears to promote clinical improvement by increasing cognitive function. […]
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally-available drug, approved in Russia for use as a non-selective antihistamine, that has shown promise in the treatment of neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. In addition to reported activity in preventing the onset and progression of disease by being neuroprotective, dimebolin appears to promote clinical improvement by increasing cognitive function. […]
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Latrepirdine is an orally active,and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug.
More Information
Supplier Page
CSNpharm
Lauric acid is a saturated medium-chain fatty acid with a 12-carbon backbone. Lauric acid is found naturally in various plant and animal fats and oils, and is a major component of coconut oil and palm kernel oil.
More Information
Supplier Page
CSNpharm
Lauric acid is a saturated medium-chain fatty acid with a 12-carbon backbone. Lauric acid is found naturally in various plant and animal fats and oils, and is a major component of coconut oil and palm kernel oil.
More Information
Supplier Page
CSNpharm
Laurocapram is a percutaneous enhancer, working by interacting with lipids in the stratum corneum. This may enhance the ability of the skin to absorb a hydrophilic chemical.
More Information
Supplier Page
CSNpharm
Laurocapram is a percutaneous enhancer, working by interacting with lipids in the stratum corneum. This may enhance the ability of the skin to absorb a hydrophilic chemical.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Lauryl gallate is the ester of dodecanol and gallic acid. As a food additive it is used under the E number E312 as an antioxidant and preservative.
More Information
Supplier Page
CSNpharm
Lauterine is a natural DNA topoisomerase inhibitor isolated and purified from the plants of Guatteria elata R. E. Fries.
More Information
Supplier Page
CSNpharm
Lauterine is a natural DNA topoisomerase inhibitor isolated and purified from the plants of Guatteria elata R. E. Fries.
More Information
Supplier Page
LC-2
50mg
| ≥98%
CSNpharm
LC-2 is the first PROTAC capable of degrading endogenous KRAS(G12C). It covalently binds KRASG12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRASG12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRASG12C cell lines.
More Information
Supplier Page
LC-2
1mg
| ≥98%
CSNpharm
LC-2 is the first PROTAC capable of degrading endogenous KRAS(G12C). It covalently binds KRASG12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRASG12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRASG12C cell lines.
More Information
Supplier Page
LC-2
25mg
| ≥98%
CSNpharm
LC-2 is the first PROTAC capable of degrading endogenous KRAS(G12C). It covalently binds KRASG12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRASG12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRASG12C cell lines.
More Information
Supplier Page
LC-2
5mg
| ≥98%
CSNpharm
LC-2 is the first PROTAC capable of degrading endogenous KRAS(G12C). It covalently binds KRASG12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRASG12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRASG12C cell lines.
More Information
Supplier Page
LC-2
10mg
| ≥98%
CSNpharm
LC-2 is the first PROTAC capable of degrading endogenous KRAS(G12C). It covalently binds KRASG12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRASG12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRASG12C cell lines.
More Information
Supplier Page
CSNpharm
LC3-mHTT-IN-1 is a mHTT-LC3 linker compound, which interacts with mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins.
More Information
Supplier Page
CSNpharm
LC3-mHTT-IN-1 is a mHTT-LC3 linker compound, which interacts with mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins.
More Information
Supplier Page
CSNpharm
LC3-mHTT-IN-1 is a mHTT-LC3 linker compound, which interacts with mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins.
More Information
Supplier Page
CSNpharm
LC3-mHTT-IN-1 is a mHTT-LC3 linker compound, which interacts with mutant huntingtin protein (mHTT) and LC3B but not with wtHTT or irrelevant control proteins.
More Information
Supplier Page